Jayne David R.W. - Insider Non-Derivative Transactions at Aurinia Pharmaceuticals Inc. (AUPH) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 21, 2024, Jayne David R.W.'s relationship to Aurinia Pharmaceuticals Inc. (AUPH) is Director, and currently has 44,364 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AUPH insiders.

Data Source: SEC.
Jayne David R.W. - Insider Non-Derivative Transactions of AUPH Common Stock
Jayne David R.W. - Insider Non-Derivative Transactions at AUPH
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
May 22, 2024 Sell -- (Common Stock) 4946 5.74 44364
May 24, 2023 Sell -- (Common Stock) 8733 11.26 49310
May 20, 2023 Acquisition -- (Common Stock) 9310 0 58043
May 19, 2023 M -- (Common Stock) 8733 0 48733